American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$313M |
| 2 |
Baker Hughes
BKR
|
+$212M |
| 3 |
Medtronic
MDT
|
+$195M |
| 4 |
PPG Industries
PPG
|
+$161M |
| 5 |
Conagra Brands
CAG
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$359M |
| 2 |
BHI
Baker Hughes
BHI
|
+$333M |
| 3 |
Microsoft
MSFT
|
+$230M |
| 4 |
EQT Corp
EQT
|
+$182M |
| 5 |
CMA
Comerica
CMA
|
+$158M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.52% |
| 2 | Healthcare | 14.08% |
| 3 | Technology | 12.82% |
| 4 | Industrials | 11.38% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Cheesecake Factory
CAKE
$5.63B
| $1.31M | ﹤0.01% |
31,110
-38,084
| -55% | -$1.7M |
|
|
FOLD
1102
DELISTED
Amicus Therapeutics
FOLD
| $1.3M | ﹤0.01% |
+86,328
| New | +$1.14M |
|
1103
TransDigm Group
TDG
$68.7B
| $1.3M | ﹤0.01% |
5,086
+1,641
| +48% | +$444K |
|
1104
Universal Corp
UVV
$1.15B
| $1.29M | ﹤0.01% |
22,553
-37,691
| -63% | -$2.25M |
|
1105
TransUnion
TRU
$15.4B
| $1.28M | ﹤0.01% |
27,168
-1,225
| -4% | -$56K |
|
1106
Stride
LRN
$3.29B
| $1.28M | ﹤0.01% |
71,861
-35,801
| -33% | -$635K |
|
|
CCRN
1107
DELISTED
Cross Country Healthcare
CCRN
| $1.27M | ﹤0.01% |
89,258
-52,792
| -37% | -$661K |
|
1108
ON Semiconductor
ON
$31.6B
| $1.27M | ﹤0.01% |
68,581
-2,894
| -4% | -$46.6K |
|
|
ALDR
1109
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.26M | ﹤0.01% |
102,731
+11,679
| +13% | +$122K |
|
|
CVGW
1110
DELISTED
Calavo Growers
CVGW
| $1.26M | ﹤0.01% |
17,161
-4,924
| -22% | -$349K |
|
|
MAG
1111
DELISTED
MAG Silver
MAG
| $1.2M | ﹤0.01% |
107,100
-22,700
| -17% | -$287K |
|
1112
Ennis
EBF
$560M
| $1.19M | ﹤0.01% |
60,782
-126,298
| -68% | -$2.41M |
|
|
XLRN
1113
DELISTED
Acceleron Pharma
XLRN
| $1.19M | ﹤0.01% |
+31,964
| New | +$1.11M |
|
|
BSTC
1114
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.19M | ﹤0.01% |
25,607
-4,854
| -16% | -$232K |
|
1115
BGC Group
BGC
$4.83B
| $1.19M | ﹤0.01% |
+127,644
| New | +$1.07M |
|
1116
Crocs
CROX
$6.31B
| $1.18M | ﹤0.01% |
+121,828
| New | +$1.04M |
|
|
AERI
1117
DELISTED
Aerie Pharmaceuticals
AERI
| $1.18M | ﹤0.01% |
24,236
+228
| +0.9% | +$12.4K |
|
|
DERM
1118
DELISTED
Dermira, Inc.
DERM
| $1.18M | ﹤0.01% |
43,546
+410
| +1% | +$10.7K |
|
1119
Aon
AON
$75.6B
| $1.17M | ﹤0.01% |
8,036
-163
| -2% | -$22.7K |
|
|
EGOV
1120
DELISTED
NIC Inc
EGOV
| $1.17M | ﹤0.01% |
68,177
-70,472
| -51% | -$1.19M |
|
|
EMCI
1121
DELISTED
EMC INS Group Inc
EMCI
| $1.14M | ﹤0.01% |
40,637
+710
| +2% | +$19.7K |
|
1122
Yelp
YELP
$1.28B
| $1.13M | ﹤0.01% |
26,068
+8,862
| +52% | +$342K |
|
|
FSB
1123
DELISTED
Franklin Financial Network, Inc.
FSB
| $1.11M | ﹤0.01% |
31,154
-44,352
| -59% | -$1.57M |
|
1124
Camden National
CAC
$982M
| $1.11M | ﹤0.01% |
25,386
+488
| +2% | +$20K |
|
1125
IQVIA
IQV
$40.1B
| $1.11M | ﹤0.01% |
11,656
| – | – |
|
Similar funds
American Century Companies's Q3 2017 Portfolio in Review
As of Q3 2017, American Century Companies held 1,460 positions worth $98.8B, up 2.2% from $96.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
American Century Companies's Q3 2017 filing shows 140 new, 562 increased, 556 reduced and 155 closed positions. Its largest new stake was Baker Hughes: 5,984,719 shares worth $219M. The largest sale was iShares Russell 1000 Value ETF, an estimated $359M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- American Century Companies's largest Q3 2017 buy was Baker Hughes: 5,984,719 shares worth $219M.
- American Century Companies added most to Meta Platforms (Facebook) in Q3 2017, an estimated $313M increase.
- American Century Companies's biggest Q3 2017 reduction was iShares Russell 1000 Value ETF, cutting an estimated $359M.
- American Century Companies fully exited Baker Hughes in Q3 2017, selling an estimated $333M.
- American Century Companies's ten largest holdings make up 14% of its $98.8B portfolio in Q3 2017.
- American Century Companies opened 140 new positions and closed 155 in Q3 2017.
- American Century Companies's portfolio value rose 2.2% quarter-over-quarter to $98.8B.
Based on American Century Companies's 13F filing for Q3 2017, filed 1 Nov 2017.